Abstract
The value of defibrillation threshold testing (DFT) has been debated in recent years, especially with developments in the technology of manufactured defibrillators, most of which are capable of delivering high energies (35 Joules [J]) and have programmable features such as tilt percentage and pulse width duration that increase the efficiency of biphasic shocks. The following is an unusual case of elevated DFT despite all attempts of invasive and noninvasive approaches--it highlights the importance of performing DFT testing particularly when implantable cardioverter defibrillator is indicated for secondary prevention of sudden cardiac death and the need for devices capable of delivering higher energies >35 J.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
